Target intelligence / Profile preview

Human parainfluenza virus 3 protein (HPIV-3 protein)

Target
HPIV-3 protein
Molecular classification
Viral protein, Glycoprotein, Enzyme, Fusion protein, Receptor-binding protein
01

Overview

Human parainfluenza virus 3 (HPIV-3) proteins are the structural and functional components of the HPIV-3 virion, which is a major cause of lower respiratory tract infections such as bronchiolitis and pneumonia in infants and immunocompromised individuals [1, 18, 22]. The viral genome encodes six primary structural proteins: the nucleocapsid (N) protein, phosphoprotein (P), matrix (M) protein, fusion (F) protein, hemagglutinin-neuraminidase (HN) protein, and the large (L) polymerase protein [1, 19, 22]. Among these, the HN and F surface glycoproteins are the most significant therapeutic targets; HN mediates viral attachment to host sialic acid receptors and possesses neuraminidase activity for viral release, while the F protein facilitates the fusion of the viral envelope with the host cell membrane [4, 13, 15, 21]. Currently, there are no FDA-approved vaccines or specific antivirals for HPIV-3, although several candidates like zanamivir and suramin have been studied for their ability to inhibit HN activity [2, 10, 18]. Other experimental approaches include host-directed therapies like DAS181, which removes the sialic acid receptors required for viral entry, and the development of monoclonal antibodies or T-cell therapies targeting the M or F proteins [4, 5, 23]. The replication complex, consisting of N, P, and L proteins, is also a potential target for inhibitors of viral RNA synthesis [1, 22]. Resistance to potential therapies can arise through mutations in the HN or F proteins, which may alter receptor binding or fusion efficiency [23]. Overall, targeting HPIV-3 proteins remains a critical area of research to address the significant morbidity and mortality associated with this virus in vulnerable populations [18, 23].

Other names
HPIV3 proteinHuman respirovirus 3 proteinHPIV-3 structural proteinHuman parainfluenza virus 3 proteins
02

Mechanism of action

Neuraminidase inhibition, viral attachment inhibition, fusion inhibition, viral replication inhibition, and host receptor depletion

03

Biological functions

Viral attachmentViral entryMembrane fusionViral replicationViral assemblyImmune evasion
04

Disease associations

InfectionCroupBronchiolitisPneumoniaRespiratory tract infection
05

Safety considerations

Drug resistanceViral mutationImmune escapeOff-target effects of host-directed therapies
06

Interacting drugs

Zanamivir

5 more in the full profile.

07

Biomarkers

Viral load (HPIV-3 RNA)HN protein expressionF protein expressionNeutralizing antibody titers

Beyond the preview

Go deeper on Human parainfluenza virus 3 protein (HPIV-3 protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human parainfluenza virus 3 protein (HPIV-3 protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call